Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.
Seranova Bio has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Seranova Bio is headquartered in New Haven, United States.
Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.
Seranova Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seranova Bio — Funding & Investors." VCBacked, February 4, 2024, https://www.vcbacked.co/company/seranova-bio. Accessed September 30, 2026.
VCBacked. (2024). Seranova Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/seranova-bio
{{cite web |title=Seranova Bio — Funding & Investors |url=https://www.vcbacked.co/company/seranova-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated